Rely+On™ Virkon™ inactivates the SARS-CoV-2 virus (COVID-19) at an economical in-use dilution rate of 1:500
May 17, 2021
Year 2021
May 2021

2021-05-12

Lanxess Press Release

NEW efficacy test demonstrates Rely+On™ Virkon™ inactivates the SARS-CoV-2 virus (COVID-19) at an economical in-use dilution rate of 1:500 – 0.2%.

With the powerful disinfectant already proven to rapidly kill the SARS-CoV-2 virus at a dilution of 1:100 -1%, in JUST 60 SECONDS on hard surfaces, floors walls, worktops etc., there was also a need to demonstrate Rely-On™ Virkon™ can inactivate the virus at a lower dilution rate. Firstly, where materials compatibility1 may be of concern, such as on carpets, soft furnishings and leather upholstery and secondly in areas where this virus is the target pathogen2.

Therefore, a recent study undertaken by an independent US microbiological test laboratory3 concluded that Rely+On™ Virkon™ inactivated the SARS-CoV-2 virus at a 1:500 / 0.2% in-use dilution rate with a CONTACT TIME of 10 MINUTES.

Visit http://coronavirus.lanxess.com to find out more regarding the applications and used of Rely+On™Virkon™ broad spectrum disinfectant against Covid-19.

 

  1. A table for Rely-On™ Virkon™ material compatibility at 1:100 and 1:500 in-use dilutions accompanies this news release.
  2. The 1:500 dilution refers to efficacy on the Target Pathogen – SARS-CoV-2 virus – and the default 1:100 in-use dilution is the ‘default’ in-use dilution for broad spectrum, multi pathogen disinfection of hard surfaces.
  3. A copy of the summary data from the independent test accompanies this news release. The summary guides the recommended practice to first prepare a 1:100/1% solution in luke warm water, allow to fully dissolve and then dilute with the appropriate volume of water to 1:500/0.2%.

 

RelyOn Virkon Materials Compatibility

RelyOn Virkon 1:500 SARS Cov